Dodge & Cox

Position in HLN — Haleon plc

CIK 200217 San Francisco, CA

Position in HLN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,398,888,950

-$67,973,076 QoQ

Shares Held

149,934,507

+2.3% QoQ

Ownership

3.41%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

of 639 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

Dodge & Cox holds $3,998,776,252 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (35.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	67,397,025	$1,658,640,785
2	HLN	Haleon plc This page	149,934,507	$1,398,888,950
3	NBIX	Neurocrine Biosciences Inc	5,584,707	$941,246,517

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,398,888,950	149,934,507	+2.3%	Shares	Sole	2026-08-13
2026-03-31	$1,466,862,026	146,539,663	-3.4%	Shares	Sole	2026-05-14
2025-12-31	$1,534,247,619	151,755,452	-1.7%	Shares	Sole	2026-02-13
2025-09-30	$1,384,830,059	154,384,622	-0.7%	Shares	Sole	2025-11-13
2025-06-30	$1,612,244,629	155,471,999	-8.1%	Shares	Sole	2025-08-13
2025-03-31	$1,740,563,131	169,150,936	-5.4%	Shares	Sole	2025-05-14
2024-12-31	$1,705,226,594	178,744,926	-0.2%	Shares	Sole	2025-02-13
2024-09-30	$1,895,643,812	179,172,383	-0.6%	Shares	Sole	2024-11-13
2024-06-30	$1,488,209,445	180,170,635	+1.8%	Shares	Sole	2024-08-13
2024-03-31	$1,502,333,100	176,953,251	+59.9%	Shares	Sole	2024-05-14
2023-12-31	$910,757,296	110,663,098	+1.2%	Shares	Sole	2024-02-22
2023-09-30	$911,284,165	109,397,859	-1.1%	Shares	Sole	2023-11-14
2023-06-30	$927,053,371	110,626,894	-1.3%	Shares	Sole	2023-08-14
2023-03-31	$912,132,624	112,055,605	+16.1%	Shares	Sole	2023-05-12
2022-12-31	$772,079,784	96,509,973	+31.5%	Shares	Sole	2023-02-14
2022-09-30	$446,796,333	73,365,572	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.